PMID: 9436754Jan 22, 1998Paper

In vitro selection of HIV-1 resistant to an anti-CD4 monoclonal antibody that inhibits virus transcription

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
N CoudronnièreC Devaux

Abstract

Phase I studies using monoclonal antibodies (mAbs) that bind to the Ig-CDR3-like loop in domain 1 of CD4 (e.g., 13B8-2 mAb) have already been documented for HIV-1-infected patients. In vitro, such mAbs do not inhibit virus to cell fusion but are able to inhibit virus envelope-mediated syncytia formation. Moreover, these mAbs inhibit Tat-induced activation of HIV-1 promoter and HIV-1 transcription in infected CD4+ cells. Here, we report the selection of escaped mutant virus or viruses derived from HIV-1Lai capable of replicating in vitro in the presence of concentrations of 13B8-2 mAb, that usually inhibit HIV-1Lai particle production. The escaped mutant virus or viruses, termed HIV-1Lai13EM, kept the major enzymatic restriction sites found in HIV-1Lai and remained sensitive to anti-CD4 mAb-, soluble CD4-, and recombinant gp120-mediated inhibition of syncytia formation. Possible genetic changes affecting the tat gene or the 5' long terminal repeat (LTR) were investigated. Partial sequence analysis of HIV-1Lai13EM and a control HIV-1Lai grown for 85 days in CEM cells, demonstrated that the first tat exon of these two viruses encoded identical proteins. Although a point mutation G>A was frequently encountered (6 of 13 sequences) i...Continue Reading

References

Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K DesaiM Green
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W S Hu, H M Temin
Nov 28, 1986·Science·Q J SattentauP C Beverley
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C E RuddS F Schlossman
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·T MizukamiB Moss
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M KowalskiJ Sodroski
Jan 1, 1987·Annual Review of Immunology·D R Littman
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P VartanianS Wain-Hobson
Feb 3, 1995·The Journal of Biological Chemistry·C A ParadaR G Roeder
Aug 30, 1994·Biochemical and Biophysical Research Communications·N ChirmuleS Pahwa
Jul 1, 1993·AIDS Research and Human Retroviruses·P J Klasse, J A McKeating

❮ Previous
Next ❯

Citations

Aug 6, 1998·Journal of Biomedical Science·N Coudronnière, C Devaux
Dec 24, 1998·The New England Journal of Medicine·S A BozzetteM F Shapiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.